FAS Wealth Partners Inc. Acquires 3,806 Shares of Intuitive Surgical, Inc. $ISRG

FAS Wealth Partners Inc. lifted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 413.2% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,727 shares of the medical equipment provider’s stock after acquiring an additional 3,806 shares during the period. FAS Wealth Partners Inc.’s holdings in Intuitive Surgical were worth $2,569,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in ISRG. Norges Bank bought a new position in Intuitive Surgical in the 2nd quarter worth approximately $2,569,260,000. Vanguard Group Inc. lifted its holdings in shares of Intuitive Surgical by 2.1% in the second quarter. Vanguard Group Inc. now owns 33,335,833 shares of the medical equipment provider’s stock worth $18,115,025,000 after buying an additional 670,302 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in shares of Intuitive Surgical by 20.1% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,393,951 shares of the medical equipment provider’s stock worth $1,680,922,000 after acquiring an additional 566,979 shares during the last quarter. Jennison Associates LLC grew its stake in Intuitive Surgical by 20.4% during the second quarter. Jennison Associates LLC now owns 3,122,390 shares of the medical equipment provider’s stock valued at $1,696,738,000 after acquiring an additional 528,359 shares in the last quarter. Finally, Wellington Management Group LLP grew its stake in Intuitive Surgical by 15.0% during the first quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider’s stock valued at $1,732,975,000 after acquiring an additional 457,080 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In related news, CEO David J. Rosa sold 24,500 shares of Intuitive Surgical stock in a transaction dated Friday, October 24th. The shares were sold at an average price of $547.55, for a total transaction of $13,414,975.00. Following the completion of the transaction, the chief executive officer directly owned 234,256 shares of the company’s stock, valued at approximately $128,266,872.80. The trade was a 9.47% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Myriam Curet sold 7,562 shares of the company’s stock in a transaction dated Tuesday, October 28th. The shares were sold at an average price of $548.43, for a total transaction of $4,147,227.66. Following the transaction, the executive vice president owned 353 shares in the company, valued at $193,595.79. The trade was a 95.54% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 109,043 shares of company stock valued at $60,816,225 over the last three months. Corporate insiders own 0.70% of the company’s stock.

Analysts Set New Price Targets

Several analysts have commented on the stock. Wall Street Zen cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Saturday, December 6th. The Goldman Sachs Group lifted their target price on Intuitive Surgical from $567.00 to $621.00 and gave the stock a “buy” rating in a report on Wednesday, October 22nd. UBS Group set a $600.00 price target on Intuitive Surgical and gave the company a “neutral” rating in a research note on Thursday, October 23rd. Daiwa Capital Markets raised their price target on Intuitive Surgical from $510.00 to $550.00 and gave the company an “outperform” rating in a report on Friday, October 24th. Finally, Mizuho set a $575.00 price objective on Intuitive Surgical in a research note on Wednesday, October 22nd. Two investment analysts have rated the stock with a Strong Buy rating, seventeen have given a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $607.17.

Intuitive Surgical Trading Down 0.4%

ISRG opened at $555.92 on Thursday. The stock has a 50-day moving average of $525.73 and a 200 day moving average of $505.69. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00. The firm has a market cap of $199.29 billion, a P/E ratio of 73.53, a P/E/G ratio of 5.13 and a beta of 1.68.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.99 by $0.41. The business had revenue of $2.51 billion during the quarter, compared to analyst estimates of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company’s revenue for the quarter was up 22.9% on a year-over-year basis. During the same period last year, the company earned $1.84 EPS. On average, research analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.